1. Home
  2. IROQ vs ENTX Comparison

IROQ vs ENTX Comparison

Compare IROQ & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IF Bancorp Inc.

IROQ

IF Bancorp Inc.

HOLD

Current Price

$27.72

Market Cap

91.6M

Sector

Finance

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.51

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IROQ
ENTX
Founded
1883
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.6M
74.7M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
IROQ
ENTX
Price
$27.72
$1.51
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
16.3K
214.4K
Earning Date
01-30-2026
03-27-2026
Dividend Yield
1.44%
N/A
EPS Growth
72.44
N/A
EPS
1.64
N/A
Revenue
$28,552,000.00
$124,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.94
N/A
Revenue Growth
17.86
25.25
52 Week Low
$23.00
$1.00
52 Week High
$29.00
$3.22

Technical Indicators

Market Signals
Indicator
IROQ
ENTX
Relative Strength Index (RSI) 59.54 49.47
Support Level $27.41 $1.45
Resistance Level $28.99 $1.49
Average True Range (ATR) 0.40 0.17
MACD 0.03 0.04
Stochastic Oscillator 32.98 75.76

Price Performance

Historical Comparison
IROQ
ENTX

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: